|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003438,
umls-concept:C0026336,
umls-concept:C0035015,
umls-concept:C0087111,
umls-concept:C0205250,
umls-concept:C0332161,
umls-concept:C0333361,
umls-concept:C0450127,
umls-concept:C0549193,
umls-concept:C1548437,
umls-concept:C1882727,
umls-concept:C1882923
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1999-3-16
|
|
pubmed:abstractText |
Antithrombin III (AT-III) is an antithrombotic agent with known anti-inflammatory properties that is also known to attenuate acute inflammation, prevent ischemia-reperfusion injury, and disseminated intravascular coagulation (DIC) associated with sepsis and endotoxemia. Here, we examined the ability of AT-III to modify parameters of acute inflammation in a highly histoincompatible model of rat lung allograft rejection (AR).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
27
|
|
pubmed:volume |
67
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
526-8
|
|
pubmed:dateRevised |
2003-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:10071021-Acute Disease,
pubmed-meshheading:10071021-Animals,
pubmed-meshheading:10071021-Antithrombin III,
pubmed-meshheading:10071021-Graft Rejection,
pubmed-meshheading:10071021-Inflammation,
pubmed-meshheading:10071021-Lung,
pubmed-meshheading:10071021-Lung Transplantation,
pubmed-meshheading:10071021-Lymphocyte Activation,
pubmed-meshheading:10071021-Male,
pubmed-meshheading:10071021-Rats,
pubmed-meshheading:10071021-Rats, Inbred BN,
pubmed-meshheading:10071021-Rats, Inbred Lew,
pubmed-meshheading:10071021-T-Lymphocytes,
pubmed-meshheading:10071021-Transplantation, Homologous
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Antithrombin III treatment improves parameters of acute inflammation in a highly histoincompatible model of rat lung allograft rejection.
|
|
pubmed:affiliation |
Department of Cardiothoracic Surgery, The Cedars-Sinai Medical Center Burns and Allen Research Institute, UCLA School of Medicine, Los Angeles, California 90048, USA.
|
|
pubmed:publicationType |
Journal Article
|
